Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:6:p33
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 6 (pt 33/36)
Character Range: 403827–406887

skin sensitisation to certain individuals;

        written in letters not less than 1.5 mm in height.
    ROTENONE except in solid or semi‑solid preparations containing 2% or less of rotenone.
    SAFROLE except:

       (a) for internal use; or

       (b) in other preparations containing 1% or less of safrole.
    SAGE OIL (Dalmatian) except:

       (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and a child‑resistant closure and compliant with the requirements of the required advisory statements for medicine labels; or

       (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 15 mL or less fitted with a restricted flow insert and a child‑resistant closure and labelled with the warnings:

          (i) KEEP OUT OF REACH OF CHILDREN; and

          (ii) NOT TO BE TAKEN; or

       (c) in preparations containing 4% or less of thujone.
    SALINOMYCIN in animal feed premixes containing 12% or less of antibiotic substances.
    SAROLANER except when included in Schedule 5.
    SASSAFRAS OIL except:

       (a) for internal use; or

       (b) in other preparations containing 1% or less of safrole.
    SELENIUM:

       (a) in preparations containing 2.5% or less of selenium when packed and labelled:

          (i) for the blueing of gun barrels; or

          (ii) for photographic purposes; or

          (iii) for the colouring of lead or lead alloys; or

       b) in coated granules containing 1% or less of selenium for application to pasture except in fertilisers containing 200 g/tonne or less of selenium; or

       (c) for the treatment of animals:

          (i) in a drench, injection, paste, stocklick, vaccine or horse feed supplement containing 0.5% or less of selenium; or

          (ii) in animal feed premixes containing 2% or less of selenium for the preparation of feeds containing 1 g/tonne or less of selenium; or

          (iii) in controlled release bolus preparations containing 25 mg or less of selenium with a release rate not greater than 0.25 mg/day; or

          (iv) as barium selenate in preparations for injection containing 5% or less of selenium.
    SEMDURAMICIN in animal feed premixes for coccidiosis prevention containing 5% or less of antibiotic substances.
    SILICOFLUORIDES except:

       (a) when included in Schedule 5; or

       (b) in preparations containing 15 mg/kg or less of fluoride ion.
    SILVER NITRATE except:

       (a) when included in or expressly excluded from Schedule 2; or

       (b) in preparations containing 1% or less of silver.
    SINBIOALLETHRIN except:

       (a) when included in Schedule 5; or

       (b) in preparations containing 1% or less of sinbioallethrin.
    SODIUM ALUMINATE (excluding its salts and derivatives) except:

       (a) in solid preparations, tHE pH of which in a 10 g/L aqueous solution is 11.5 or less; or

       (b) in liquid preparations, tHE pH of which